Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of Basiliximab, With Concomitant Corticosteroids, in Steroid-Refractory Ulcerative Colitis

NCT00430898 is registered in ClinicalTrials.gov with Cerimon Pharmaceuticals as lead sponsor.

NCT NCT00430898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00430898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of Basiliximab, With Concomitant Corticosteroids, in Steroid-Refractory Ulcerative Colitis
Lead sponsor
Cerimon Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2007
Completion date
September 30, 2008
Enrollment
181 (estimated)
Sites
68

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis